Interní Med. 2006; 8(1): 14-17

Arterial hypertension and strokes

doc. MUDr. Jan Filipovský CSc
II. interní klinika LF UK a FN, Plzeň

Strokes are typical complications of long-lasting hypertension and the treatment of high blood pressure decreases their incidence significantly. In patients with high risk for cardiovascular events, combination therapy with lower doses of metabolically neutral medication, especially dihydropyrimidine type calcium blockers and ACE inhibitors, appears to be the most suitable. Beta-blockers seem to be less effective especially in elderly patients. In patients who already underwent the stroke the antihypertensive therapy lowers the probability of recurrence and it is also in those whose blood pressure is considered normal according to valid classification. The evidence for this treatment was gathered mainly for the combination of ACE inhibitor and a diuretic. We do not have definite evidence for the optimal management of acute stroke. However, radical blood pressure lowering is surely unsuitable. The use of small dose angiotensine II receptors blockers appears to be safe.

Keywords: Key words: strokes, primary prevention, hypertension after the stroke, management of acute stroke.

Published: March 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Filipovský J. Arterial hypertension and strokes. Interní Med. 2006;8(1):14-17.
Download citation

References

  1. Dahlöf B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. The Lancet 2005; 366: 895-906. Go to original source... Go to PubMed...
  2. Chalmers J, Beilin L, Mancia G, et al. International Society of Hypertension: statements on blood pressure and stroke. J Hypertension 2003; 21: 649-650. Go to original source...
  3. Mancia G, Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens 2002; 20: 1461-1464. Go to original source... Go to PubMed...
  4. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. The Lancet 2001; 358: 1033-1041. Go to original source... Go to PubMed...
  5. Schrader J, Luders S, Kulschewski A, et al. The ACCESS Study. Evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 2003; 34: 1699-1703. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.